Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine

about

A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent.

P2860

Q45077774-35D0CC53-6F62-4749-B2C6-C5963F404074

P2860

Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine

Item

http://www.wikidata.org/entity/Q42783189

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Adoptive Immunotherapy after A ...... tives for Transfusion Medicine

@en

Adoptive Immunotherapy after A ...... tives for Transfusion Medicine

@nl

type

Item

label

Adoptive Immunotherapy after A ...... tives for Transfusion Medicine

@en

Adoptive Immunotherapy after A ...... tives for Transfusion Medicine

@nl

prefLabel

Adoptive Immunotherapy after A ...... tives for Transfusion Medicine

@en

Adoptive Immunotherapy after A ...... tives for Transfusion Medicine

@nl

P1476

Adoptive Immunotherapy after A ...... tives for Transfusion Medicine

@en

P2093

Jochen Greiner

http://www.w3.org/2001/XMLSchema#string

Susanne Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Cancer regression in patients after transfer of genetically engineered lymphocytes

The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice

P304

173-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000328898

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51494108

http://www.w3.org/2001/XMLSchema#string

P698

21760761

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

3128149

http://www.w3.org/2001/XMLSchema#string

Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine

about

P2860

P2860

Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932